BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koopaie M, Kolahdooz S, Fatahzadeh M, Manifar S. Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta-analysis. Cancer Med 2022. [PMID: 35315584 DOI: 10.1002/cam4.4640] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Robotti M, Scebba F, Angeloni D. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics? Biomedicines 2023;11:652. [DOI: 10.3390/biomedicines11030652] [Reference Citation Analysis]
2 Sinha I, Fogle RL, Gulfidan G, Stanley AE, Walter V, Hollenbeak CS, Arga KY, Sinha R. Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study. Int J Mol Sci 2023;24. [PMID: 36835577 DOI: 10.3390/ijms24044164] [Reference Citation Analysis]
3 Neagu AN, Jayathirtha M, Whitham D, Mutsengi P, Sullivan I, Petre BA, Darie CC. Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer. Proteomes 2022;10:35. [PMID: 36278695 DOI: 10.3390/proteomes10040035] [Reference Citation Analysis]
4 Grootveld M, Percival BC, Page G, Hunwin K, Bhogadia M, Chan W, Edgar M. Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part II: Applications to the Diagnosis and Prognostic Monitoring of Oral and Systemic Cancers. Metabolites 2022;12:778. [DOI: 10.3390/metabo12090778] [Reference Citation Analysis]
5 Bel'skaya LV, Sarf EA. Prognostic Value of Salivary Biochemical Indicators in Primary Resectable Breast Cancer. Metabolites 2022;12:552. [PMID: 35736486 DOI: 10.3390/metabo12060552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]